oseltamivir [Tamiflu]

DRUG5 trials

Sponsors

Hoffmann-La Roche, Genentech, Inc.

Conditions

Healthy VolunteerInfluenza

Phase 1

A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza

CompletedNCT01033734

Hoffmann-La RocheInfluenza

Start: 2010-12-31End: 2012-12-31Updated: 2016-08-24

A Pharmacokinetic Study on Co-administration of Tamiflu (Oseltamivir) and Rimantadine in Healthy Volunteers

CompletedNCT01172847

Hoffmann-La RocheHealthy Volunteer

Start: 2009-08-31End: 2010-02-28Updated: 2016-08-19

Phase 2

A Study of MHAA4549A in Healthy Volunteers in an Influenza Challenge Model

CompletedNCT01980966

Genentech, Inc.Healthy Volunteer

Start: 2013-11-25End: 2014-06-19Updated: 2017-03-09

Phase 4

A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.

CompletedNCT00412555

Hoffmann-La RocheInfluenza

Start: 2006-12-31End: 2007-05-31Updated: 2020-08-18

A Study of Tamiflu (Oseltamivir) Treatment in Laboratory-Confirmed Influenza.

TerminatedNCT00436124

Hoffmann-La RocheInfluenza

Start: 2007-01-31End: 2007-04-30Updated: 2017-02-17

Related Papers

Pharmacokinetics of MHAA4549A, an Anti-Influenza A Monoclonal Antibody, in Healthy Subjects Challenged with Influenza A Virus in a Phase IIa Randomized Trial.

2018-03-0123 citations

Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model

Antimicrobial Agents and Chemotherapy2017-08-1575 citations

Pharmacokinetics and safety of intravenous oseltamivir in infants and children in open-label studies.

2015-07-013 citations